Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

US Patent 7906123 · Granted Mar 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aptamer-based CAR T-cell switch2025
Viral vector constructs for expression of genetic adjuvants activating the CD40 2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Monomeric and functional adenylate cyclase CyaA toxin2021
Method for preparing multiple antigen glycopeptide carbohydrate conjugates2021
In vivo detection of proteins interaction based on adenylate cyclase hybrid syst2020
Lentiviral vectors for regulated expression of a chimeric antigen receptor molec2020
Lyophilized lentiviral vector particles, compositions and methods2020
Vectors for molecule delivery to CD11b expressing cells2018
Vectors for molecule delivery to CD11b expressing cells2018
Vectors for molecule delivery to CD11b expressing cells2018
Lentiviral vectors for generating immune responses against human T Lymphotrophic2018